Skip to main content

Optical Redox Imaging Monitors Heart Cell Development






An optical imaging tool for monitoring the growth of human heart cells known as cardiomyocytes (CMs) could lead to a reproducible means to generate human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for biomanufacturing. The imaging technique, along with various synthetic hydrogel substrates, was developed by a team at the University of Wisconsin-Madison.

CMs derived from iPSCs are a promising tool for combatting heart disease, which is a leading cause of death worldwide. IPSCs can be used to improve drug screening platforms, build accurate disease models, and develop personalized regenerative medical treatments. They can be reprogrammed to generate high-purity CM batches. However, in vitro maturation of iPSC-CMs remains difficult.

IPSC-CM differentiation and maturation studies typically rely on heterogeneous substrates and destructive verification methods. The technique that is traditionally used to grow iPSC-CMs is highly variable, prone to contamination, and degrades easily over time. The assays used to screen CM cells to determine their maturity often require harsh chemicals that damage the cells.

The University of Wisconsin-Madison team recognized that a touch-free monitoring approach and tunable substrates might provide a way to produce homogenous, functional CM cells and determine the ideal conditions for the cells’ successful growth.

The researchers developed a label-free, wide-field optical imaging technique to observe live CM cells throughout their differentiation and early-to-late maturation and identify key metabolic shifts in the cells. They grew the cells on synthetic, in-house developed hydrogels.

Using autofluorescence lifetime imaging (FLIM), the researchers verified increased oxidative metabolism and NAD(P)H protein binding activity throughout cell differentiation. To increase throughput and screen more hydrogel formulations, they used widefield NAD(P)H and FAD autofluorescence imaging to calculate the optical redox ratio at multiple timepoints throughout differentiation. The optical redox ratio represents the metabolic shifts in the cells’ energy production and consumption.

The researchers developed several different compositions of synthetic, modifiable hydrogels to induce stem cell differentiation and maturation. Their approach to formulating the gels led to uniform results.

“The goal is having something that will be tunable and reproducible,” researcher Danielle Desa said. “The dream application of using these synthetic materials would be for biomanufacturing, because you’d want something robust and repeatable.”

The researchers found that the optical redox ratio decreased in CMs grown in all the synthetic hydrogel formulations during differentiation, early maturation, and late maturation. These results indicate that the CMs’ metabolic pathways shifted from glycolysis (i.e., breakdown of glucose to access energy quickly) to oxidative phosphorylation (i.e., use of oxygen to produce energy).

The team screened CMs grown in the hydrogels out to 100 days post-differentiation and continued to see metabolic changes over that period. “It was useful to see that they didn’t degrade in that time,” Desa said. “We wanted to do repeated imaging on the same gels over time and see if the technique was sensitive to any metabolic changes.”

The researchers also observed metabolic differences in low- and high-efficiency differentiation batches of cells. The sensitivity of the optical redux imaging technique could serve as an early predictor of which batch of cells is most likely to mature into functional CMs. This feature could make optical redux imaging a useful screening tool for cell manufacturing.

The efficient production and widespread use of iPSC-CMs will require consistent manufacturing of functionally mature cell batches and touch-free, nondestructive monitoring. The optical redux imaging technique and synthetic hydrogels could provide an accessible, medium-throughput method to monitor iPSC metabolism in response to interventions that aim to increase batch yield, consistency, and maturity without manipulating or destroying the cells. The technique allows the same cells to be monitored repeatedly and used for complementary analyses.


Bio Photonics Research Award

Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...